242 related articles for article (PubMed ID: 17217681)
41. [Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease].
Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK; Loshchits NV
Ter Arkh; 2004; 76(3):62-8. PubMed ID: 15108463
[TBL] [Abstract][Full Text] [Related]
42. [Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure].
Song HM; Zhang J; Deng B; Luo M
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1737-40. PubMed ID: 16253158
[TBL] [Abstract][Full Text] [Related]
43. β1-Adrenergic receptor Arg389Gly polymorphism affects the antiarrhythmic efficacy of flecainide in patients with coadministration of β-blockers.
Doki K; Sekiguchi Y; Kuga K; Aonuma K; Homma M
Pharmacogenet Genomics; 2016 Oct; 26(10):481-5. PubMed ID: 27500822
[TBL] [Abstract][Full Text] [Related]
44. Beta-blockade treatment in heart failure: the cardiac insufficiency bisoprolol study (CIBIS) project. CIBIS Committees and Investigators. Cardiac Insufficiency Bisoprolol Study.
Lechat P
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S158-63. PubMed ID: 11534531
[TBL] [Abstract][Full Text] [Related]
45. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
[TBL] [Abstract][Full Text] [Related]
46. Is there a role of the Thr164Ile-beta(2)-adrenoceptor polymorphism for the outcome of chronic heart failure?
Leineweber K; Tenderich G; Wolf C; Wagner S; Zittermann A; Elter-Schulz M; Moog R; Müller N; Jakob HG; Körfer R; Philipp T; Heusch G; Brodde OE
Basic Res Cardiol; 2006 Nov; 101(6):479-84. PubMed ID: 16783489
[TBL] [Abstract][Full Text] [Related]
47. Polymorphisms of adrenoceptors are not associated with an increased risk of adverse event in heart failure: a MERIT-HF substudy.
Savva J; Maqbool A; White HL; Galloway SL; Yuldasheva NY; Ball SG; West RM; De Boer RA; Van Veldhuisen DJ; Balmforth AJ;
J Card Fail; 2009 Jun; 15(5):435-41. PubMed ID: 19477404
[TBL] [Abstract][Full Text] [Related]
48. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
[TBL] [Abstract][Full Text] [Related]
49. Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure.
de Groote P; Helbecque N; Lamblin N; Hermant X; Mc Fadden E; Foucher-Hossein C; Amouyel P; Dallongeville J; Bauters C
Pharmacogenet Genomics; 2005 Mar; 15(3):137-42. PubMed ID: 15861037
[TBL] [Abstract][Full Text] [Related]
50. [Relationship between plasma brain natriuretic peptide concentration and clinical prognosis in patients of acute myocardial infarction].
Wang LF; Wu S; Guan XR; Zhang L; Shen JX; Xue FH
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Mar; 33(3):234-7. PubMed ID: 15929819
[TBL] [Abstract][Full Text] [Related]
51. Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes.
Parikh KS; Fiuzat M; Davis G; Neely M; Blain-Nelson P; Whellan DJ; Abraham WT; Adams KF; Felker GM; Liggett SB; O'Connor CM; Bristow MR
Circ Genom Precis Med; 2018 Aug; 11(8):e002210. PubMed ID: 30354340
[TBL] [Abstract][Full Text] [Related]
52. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.
Lanfear DE; Jones PG; Marsh S; Cresci S; McLeod HL; Spertus JA
JAMA; 2005 Sep; 294(12):1526-33. PubMed ID: 16189366
[TBL] [Abstract][Full Text] [Related]
53. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
[TBL] [Abstract][Full Text] [Related]
54. The common Arg389gly ADRB1 polymorphism affects heart rate response to the ultra-short-acting β(1) adrenergic receptor antagonist esmolol in healthy individuals.
Muszkat M; Hoofien A; Orlanski-Meyer E; Makhoul H; Porat E; Davidson EM; Blotnick S; Caraco Y
Pharmacogenet Genomics; 2013 Jan; 23(1):25-8. PubMed ID: 23114278
[TBL] [Abstract][Full Text] [Related]
55. [BNP and echocardiography can predict the occurrence of acute cardiac decompensation during titration of bisoprolol in chronic systolic heart failure].
Ben Driss A; Tabet JY; Meurin P; Weber H; Renaud N; Grosdemouge A; Bourmayan C
Arch Mal Coeur Vaiss; 2007 Nov; 100(11):934-40. PubMed ID: 18209694
[TBL] [Abstract][Full Text] [Related]
56. [Clinical, hemodynamic and neurohumoral effects of switching patients with chronic heart failure from not recommended -adrenoblockers to bisoprolol in ambulatory practice].
Ageev FT; Zhubrina ES; Ovchinnikov AG; Seredenina EM
Kardiologiia; 2010; 50(6):41-7. PubMed ID: 20659026
[TBL] [Abstract][Full Text] [Related]
57. [Response to metoprolol succinate sustained-release tablets in correlation to pulse pressure, serum vascular endothelial growth factor and C-reactive protein in elderly hypertensive patients with chronic heart failure].
Zhang ZW; Lin ZP
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Sep; 30(9):2171-4. PubMed ID: 20855282
[TBL] [Abstract][Full Text] [Related]
58. Response to catecholamine stimulation of polymorphisms of the beta-1 and beta-2 adrenergic receptors.
McLean RC; Baird SW; Becker LC; Townsend SN; Gerstenblith G; Kass DA; Tomaselli GF; Schulman SP
Am J Cardiol; 2012 Oct; 110(7):1001-7. PubMed ID: 22742717
[TBL] [Abstract][Full Text] [Related]
59. Beta-adrenoceptor blocker treatment and the cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure.
Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 2007 Feb; 374(5-6):361-72. PubMed ID: 17216434
[TBL] [Abstract][Full Text] [Related]
60. Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy.
Terra SG; Hamilton KK; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hill JA; Aranda JM; Yarandi HN; Johnson JA
Pharmacogenet Genomics; 2005 Apr; 15(4):227-34. PubMed ID: 15864115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
